↑ Injective Coin: Rising Star in the Cryptocurrency Market

In a recent flurry of activity in the cryptocurrency space, Injective Coin has been making waves. The U.S. Securities and Exchange Commission (SEC) has invited public feedback regarding a proposed staked Injective exchange-traded fund (ETF) listing. This has sparked substantial interest from investors and crypto enthusiasts alike, as the filing was made by Canary Capital. Furthermore, Cboe has also filed to list this staked Injective ETF. This development was accompanied by a spike in Injective's price, with predictions indicating a potential for a new all-time high this year.

Crypto media outlet Cointelegraph has partnered with Injective to accelerate the growth of their joint ecosystem. Through an ambitious 12-Week DeFi Startup Acceleration Program, the partnership aims to fund and nurture upcoming projects in the DeFi space. Injective's price has reportedly been hovering near the $16 resistance level, and the number of Injective wallets has surged 40% in two months.

Remittax and Avalanche are among the enterprises that have highlighted Injective for potential gains in 2025. Injective has also hit the spotlight with Deutsche Telekom subsidiary becoming a validator for its blockchain. This speaks volumes about the coin's growing acceptance among established entities.

Injective is trending in anticipation of an Ethereum Virtual Machine (EVM) testnet launch, poised to potentially drive the coin's price towards $12. In more signs of mainstream acceptance, Canary Capital has continued its altcoin ETF strategy with an application to launch a fund with Injective staking. In light of these developments, many experts believe that this novel PayFi token has the potential to sustain its parabolical run.

Injective Coin News Analytics from Mon, 07 Nov 2022 21:11:30 GMT to Wed, 27 Aug 2025 01:00:53 GMT - Rating 6 - Innovation 8 - Information 7 - Rumor 8